CVDP CANCER VACCINE DEVELOPMENT PROGRAM

Serial Number 86759908
Registration 5006207
710

Registration Progress

Application Filed
Sep 17, 2015
Under Examination
Approved for Publication
May 10, 2016
Published for Opposition
May 10, 2016
Registered
Jul 26, 2016

Trademark Image

CVDP CANCER VACCINE DEVELOPMENT PROGRAM

Basic Information

Serial Number
86759908
Registration Number
5006207
Filing Date
September 17, 2015
Registration Date
July 26, 2016
Published for Opposition
May 10, 2016
Cancellation Date
February 10, 2023
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Feb 10, 2023

Rights Holder

CANCER INSIGHT HOLDINGS, LLC

16
Address
1100 EAST HOUSTON STREET, FLOOR 7
SAN ANTONIO, TX 78205

Ownership History

Peoples MD, George E.

Original Applicant
01
San Antonio, TX

Peoples MD, George E.

Owner at Publication
01
San Antonio, TX

CANCER INSIGHT HOLDINGS, LLC

New Owner After Publication #1
16
SAN ANTONIO, TX

CANCER INSIGHT HOLDINGS, LLC

Original Registrant
16
SAN ANTONIO, TX

Legal Representation

Attorney
William G. Barber

USPTO Deadlines

Next Deadline
378 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-07-26)
Due Date
July 26, 2026
Grace Period Ends
January 26, 2027

Application History

32 events
Date Code Type Description
Feb 10, 2023 C8.. O CANCELLED SEC. 8 (6-YR)
Jul 26, 2021 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 26, 2016 R.PR A REGISTERED-PRINCIPAL REGISTER
May 25, 2016 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 10, 2016 PUBO A PUBLISHED FOR OPPOSITION
May 10, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 20, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 1, 2016 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 31, 2016 CNEA R EXAMINERS AMENDMENT -WRITTEN
Mar 31, 2016 GNEA O EXAMINERS AMENDMENT E-MAILED
Mar 31, 2016 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 31, 2016 XAEC I EXAMINER'S AMENDMENT ENTERED
Mar 21, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2016 ALIE A ASSIGNED TO LIE
Mar 10, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 17, 2016 CNRT R NON-FINAL ACTION WRITTEN
Feb 17, 2016 GNRT O NON-FINAL ACTION E-MAILED
Feb 17, 2016 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 27, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 26, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2016 CEPE I COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Jan 12, 2016 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Jan 12, 2016 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jan 12, 2016 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jan 12, 2016 ALIE A ASSIGNED TO LIE
Jan 5, 2016 DOCK D ASSIGNED TO EXAMINER
Sep 22, 2015 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 21, 2015 NWAP I NEW APPLICATION ENTERED
Sep 21, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Additional Information

Design Mark
The mark consists of a stylized representation of three people holding hands standing on a crescent shape above the words "CVDP CANCER VACCINE DEVELOPMENT PROGRAM" in a stacked presentation.
Color Claim
Color is not claimed as a feature of the mark.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"CANCER VACCINE DEVELOPMENT PROGRAM"

USPTO Documents

Click to view cached USPTO documents for this trademark

Only administrators can request new documents from USPTO